LIVE MARKET TRACKER :   BSE SENSEX        |    NSE NIFTY    
GLOBAL MARKETS :  NASDAQ      |    FSI London      |    NIKKEI Japan  
  USD GBP EUR CAD AUD INR
USD -
GBP -
EUR -
CAD -
AUD -
INR -
Indian-Commodity  :  Equity & Shares  :  Dr. Lal PathLabs rises with arm receiving nod to acquire Satya Pathology and Diagnostic Centre

Dr. Lal PathLabs rises with arm receiving nod to acquire Satya Pathology and Diagnostic Centre (13-Dec-2017)

Dr. Lal PathLabs is currently trading at Rs. 885.90, up by 7.35 points or 0.84% from its previous closing of Rs. 878.55 on the BSE.

The scrip opened at Rs. 904.00 and has touched a high and low of Rs. 904.00 and Rs. 882.30 respectively.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1134.50 on 10-Jan-2017 and a 52 week low of Rs. 717.65 on 24-Oct-2017.

Last one week high and low of the scrip stood at Rs. 904.00 and Rs. 870.00 respectively. The current market cap of the company is Rs. 7,382.00 crore.

The promoters holding in the company stood at 57.92%, while Institutions and Non-Institutions held 21.92% and 20.17% respectively.

Dr. Lal PathLabs' subsidiary -- Paliwal Diagnostics has received an approval to acquire a Proprietorship Concern. i.e. Satya Pathology and Diagnostic Centre (SPDC).  The Board of Directors of the company's Subsidiary at their meeting held on December 12, 2017, approved the same.

The company's subsidiary has decided to acquire 100% stake in SPDC with the objective of strengthening its presence in market.

Dr. Lal PathLabs is a provider of diagnostic and related healthcare tests and services in India. Through its integrated, nationwide network, the company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.



Top News Today
Rama Vision gets appointed as distributor of Nuby's products
(21-Feb-2018)

Rama Vision gets appointed as distributor of NubyRama Vision has been appointed as the distributor of Nuby's products of Nuby Asia Pacific, which is an established Baby Care Brand of USA for distribution of all its infant care products in India.Rama......click on news to read complete article.

Parag Milk Foods wins two awards for 'Gowardhan Ghee'
(21-Feb-2018)

Parag Milk Foods wins two awards for Parag Milk Foods has received two prestigious awards for its flagship product - Gowardhan Ghee. Consumer Voice ranked Gowardhan Ghee as No. 1 in product testing and The Brand Trust Report declared Gowardhan......click on news to read complete article.

IRIS Business Services bags two orders in South Africa
(21-Feb-2018)

IRIS Business Services bags two orders in South AfricaSouth Africa's business registry, the Competition and Intellectual Property commission (CIPC) has launched its pilot XBRL filing program with technology from global XBRL major, IRIS Business Services.Additionally,......click on news to read complete article.

International Stock News
Asian markets trade mostly higher in early deals on Wednesday
(21-Feb-2018)

Asian markets trade mostly higher in early deals on WednesdayAsian equity benchmarks are trading mostly in green in early deals on Wednesday, supported by better-than-expected manufacturing data from Japan. The gains came despite losses on Wall Street, where a six-day......click on news to read complete article.

Asian markets trade mostly higher in early deals on Wednesday
(21-Feb-2018)

Asian markets trade mostly higher in early deals on WednesdayAsian equity benchmarks are trading mostly in green in early deals on Wednesday, supported by better-than-expected manufacturing data from Japan. The gains came despite losses on Wall Street, where a six-day......click on news to read complete article.

US markets snap six-day winning streak
(21-Feb-2018)

US markets snap six-day winning streakThe US market snapped six-day winning streak on Tuesday, with the Dow and S&P 500 weighed down by a steep loss for Walmart as investors also watched climbing bond yields, which could make equities......click on news to read complete article.

 

     
  
Recent Equity & Shares News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.